CPT code 66711 denotes a laser cyclodestruction procedure in which part of the ciliary body is destroyed to decrease aqueous humor production and lower intraocular pressure. This ophthalmic intervention is used in the management of glaucoma or ocular hypertension when reduction of fluid production is indicated without removal of the crystalline lens. Nationally, the code is relevant to ophthalmology practices, ambulatory surgical centers, and payers managing glaucoma treatment pathways.

Key payers commonly involved in coverage and reimbursement for this service include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical intent of the code, typical settings where the procedure is performed, and the payers engaged in its coverage. The publication also presents benchmarks and policy context relevant to outpatient ophthalmic procedures, coding considerations for reporting the service, and the clinical scenarios in which cyclodestruction is typically considered.

The content is intended to inform billing professionals, practice administrators, and clinical leaders about the purpose of 66711, where it is performed, and the payer landscape affecting reimbursement and utilization nationally. Data not available in the input is noted where applicable.